Close Menu
Home » Precipio to Effect 1-for-15 Reverse Stock Split

Precipio to Effect 1-for-15 Reverse Stock Split

Apr 26, 2019
|
staff reporter

NEW YORK (GenomeWeb) — Cancer diagnostics developer Precipio said today that it will implement a 1-for-15 reverse stock split in a bid to regain compliance with a Nasdaq listing requirements.

In a filing with the US Securities and Exchange Commission, New Haven, Connecticut-based firm said that it received notice late last month that it did not meet the exchange's $1 minimum bid price requirement and that its stock was facing delisting.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Keep Them or Not?

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

Dunno Whose It Is

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

Knowing Risk From a Young Age

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

Science Translational Medicine Paper Finds Drug Combo Boosts KRAS Inhibitor Efficacy in Lung Cancer

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.

Sep
25
Featured Webinar

Biomarker Evaluation for CAR T-Cell Therapy: Impact on Drug Development

Sponsored by
HalioDx

CAR T-cell therapy is an innovative form of immunotherapy that is finding increasing use for the management of blood cancers. 

Oct
08
Featured Webinar

Integration of Single Cell and Spatially Resolved Methods for Understanding Neurodegeneration in ALS

Sponsored by
10x Genomics

This webinar will discuss a study that used spatial transcriptomics to gain insight into the molecular mechanisms of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease.

Oct
10
Featured Webinar

Laboratory Validation of a Kit-Based Liquid Biopsy NGS Assay

Sponsored by
Roche

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
21
Featured Webinar

Broad Genomic Testing for Oncology Clinical Trials and Clinical Practice

Sponsored by
Agilent

Genomics is a key element in the potential of precision medicine to transform oncology. 

What's Popular?

In Molecular Diagnostics

  1. Roche Gains FDA Clearance for Cobas Babesia Blood Test

  2. Germany's Publicly Funded Insurance to Cover NIPT Under Limited Circumstances

  3. HTG Molecular Diagnostics Prices $20M in Stock Offerings

  4. Bionano Genomics Commences Public Stock Offering

  5. Inex Innovate to Launch New Molecular Tests for Ovarian Cancer, Breast Cancer in Asia

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.